The growing burden of endometrial cancer: A major racial disparity affecting black women

Cancer Epidemiology Biomarkers and Prevention

Volumn 24, Issue 9, 2015, Pages 1407-1415

  Cote, Michele L ^a,b   Ruterbusch, Julie J ^a   Olson, Sara H ^c   Lu, Karen ^d   Ali Fehmi, Rouba ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b KARMANOS CANCER INSTITUTE   (United States)

^c MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; AMERICAN INDIAN; ARTICLE; ASIAN; BLACK PERSON; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CARCINOSARCOMA; CAUCASIAN; CLEAR CELL CARCINOMA; CLEAR CELL ENDOMETRIAL CANCER; CONTROLLED STUDY; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ETHNICITY; FEMALE; HEALTH DISPARITY; HIGH GRADE ENDOMETRIOID ENDOMETRIAL CANCER; HISPANIC; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALIGNANT MULLERIAN MIXED TUMOR; MIDDLE AGED; MIXED MULLERIAN TUMOR; POPULATION RESEARCH; PRIORITY JOURNAL; RACE DIFFERENCE; VERY ELDERLY; ADENOCARCINOMA; AFRICAN AMERICAN; ASIAN AMERICAN; CANCER GRADING; CANCER STAGING; ENDOMETRIUM TUMOR; EPIDEMIOLOGY; ETHNOLOGY; INCIDENCE; MORTALITY; NEOPLASM; PATHOLOGY; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADENOCARCINOMA, CLEAR CELL; AFRICAN AMERICANS; AGED; AGED, 80 AND OVER; ASIAN AMERICANS; CARCINOMA, ENDOMETRIOID; CARCINOSARCOMA; ENDOMETRIAL NEOPLASMS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HEALTH STATUS DISPARITIES; HUMANS; INCIDENCE; MIDDLE AGED; MIXED TUMOR, MULLERIAN; NEOPLASM GRADING; NEOPLASM STAGING; NEOPLASMS, CYSTIC, MUCINOUS, AND SEROUS; UNITED STATES;

EID: 84941761608     PISSN: 10559965     EISSN: 15387755     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-15-0316     Document Type: Article

References (43)

1. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA Cancer J Clin 2013;63:11-30.
2. Wartko P, Sherman ME, Yang HP, Felix AS, Brinton LA, Trabert B. Recent changes in endometrial cancer trends among menopausal-age U.S. women. Cancer Epidemiol 2013;37:374-7.
3. Sheikh MA, Althouse AD, Freese KE, Soisson S, Edwards RP, Welburn S, et al. USA endometrial cancer projections to 2030: should we be concerned? Future Oncol 2014;10:2561-8.
4. Duncan ME, Seagroatt V, Goldacre MJ. Cancer of the body of the uterus: trends in mortality and incidence in England, 1985-2008. BJOG 2012; 119:333-9.
5. Cowie CC, Rust KF, Byrd-Holt DD, Gregg EW, Ford ES, Geiss LS, et al. Prevalence of diabetes and high risk for diabetes using A1C criteria in theU. S. population in 1988-2006. Diabetes Care 2010;33:562-8.
6. Friberg E, Orsini N, Mantzoros CS, Wolk A. Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 2007;50:1365-74.
7. Edwards BK, Noone AM, Mariotto AB, Simard EP, Boscoe FP, Henley SJ, et al. Annual Report to the Nation on the status of cancer, 1975-2010, featuring prevalence of comorbidity and impact on survival among persons with lung, colorectal, breast, or prostate cancer. Cancer 2014; 120:1290-314.
8. Jamison PM, Noone AM, Ries LA, Lee NC, Edwards BK. Trends in endometrial cancer incidence by race and histology with a correction for the prevalence of hysterectomy, SEER 1992 to 2008. Cancer Epidemiol Biomarkers Prev 2013;22:233-41.
9. Long B, Liu FW, Bristow RE. Disparities in uterine cancer epidemiology, treatment, and survival among African Americans in the United States. Gynecol Oncol 2013;130:652-9.
10. Collins Y, Holcomb K, Chapman-Davis E, Khabele D, Farley JH. Gynecologic cancer disparities: a report from the Health Disparities Taskforce of the Society of Gynecologic Oncology. Gynecol Oncol 2014; 133:353-61.
11. DeSantis C, Naishadham D, Jemal A. Cancer statistics for African Americans, 2013. CA Cancer J Clin 2013;63:151-66.
12. Farley J, Risinger JI, Rose GS, Maxwell GL. Racial disparities in blacks with gynecologic cancers. Cancer 2007;110:234-43.
13. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64:9-29.
14. Mahdi H, Hou H, Kowk LL, Moslemi-Kebria M, Michener C. Type II endometrial cancer in Hispanic women: tumor characteristics, treatment and survival compared to non-Hispanic white women. Gynecol Oncol 2014;133:512-7.
15. Mahdi H, Schlick CJ, Kowk LL, Moslemi-Kebria M, Michener C. Endometrial cancer in Asian and American Indian/Alaskan Native women: tumor characteristics, treatment and outcome compared to non-Hispanic white women. Gynecol Oncol 2014;132:443-9.
16. Simons E, Blansit K, Tsuei T, Brooks R, Ueda S, Kapp DS, et al. Foreign-vs US-born Asians and the association of type I uterine cancer. Am J Obstet Gynecol 2015;212:43 e1-6.
17. Surveillance Epidemiology and End Results. SEER-Stat Database: Incidence-SEER 18 Regs Reserach Data+ Hurricane Katrina Impacted Louisiana Cases, Nov 2013 Sub (1973-2011 varying)-Linked to Country Attributes-Total U.S., 1969-2012 Counties. In:National Cancer Institute D Surveillance Research Program, Surveillance Systems Branch, editor. released April 2014 (updated 5/7/2014), based on the November 2013 submission ed2014.
18. National Cancer Institute Department of Health and Human Services. SEER as a research resource; 2010. Available from: http://seer.cancer.gov/about/factsheets/SEER-Research-Brochure.pdf.
19. Fritz A PC, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, Whelan S. International Classification of Diseases for Oncology. 3rd ed. Geneva: World Health Organization; 2000.
20. Soslow RA. High-grade endometrial carcinomas-strategies for typing. Histopathology 2013;62:89-110.
21. Creasman WT, Odicino F, Maisonneuve P, Quinn MA, Beller U, Benedet JL, et al. Carcinoma of the corpus uteri. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer. Int J Gynaecol Obstet 2006;95 Suppl 1:S105-43.
22. Tiwari RC, Clegg LX, Zou Z. Efficient interval estimation for age-adjusted cancer rates. Stat Methods Med Res 2006;15:547-69.
23. Cho H, Howlader N, Mariotto AB, Cronin KA. Estimating relative survival for cancer patients from the SEER Program using expected rates based on Ederer I versus Ederer II method. In:Surveillance Research Program NCI, editor. 2011.
24. Surveillance Research Program National Cancer Institute. SEER-tat software. version 8.1.5 ed. 2014.
25. Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States. Cancer Res 2014;74:2913-21.
26. Gomez SL, Noone AM, Lichtensztajn DY, Scoppa S, Gibson JT, Liu L, et al. Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst 2013;105: 1096-110.
27. Sabatino SA, Stewart SL, Wilson RJ. Racial and ethnic variations in the incidence of cancers of the uterine corpus, United States, 2001-2003. J Womens Health 2009;18:285-94.
28. Setiawan VW, Yang HP, PikeMC, McCann SE, Yu H, Xiang YB, et al. Type I and II endometrial cancers: have they different risk factors? J Clin Oncol 2013;31:2607-18.
29. Yang HP, Wentzensen N, Trabert B, Gierach GL, Felix AS, Gunter MJ, et al. Endometrial cancer risk factors by 2 main histologic subtypes: the NIHAARP Diet and Health Study. Am J Epidemiol 2013;177:142-51.
30. Bokhman JV. Two pathogenetic types of endometrial carcinoma. Gynecol Oncol 1983;15:10-7.
31. Brinton LA, Felix AS, McMeekin DS, Creasman WT, Sherman ME, Mutch D, et al. Etiologic heterogeneity in endometrial cancer: evidence from a Gynecologic Oncology Group trial. Gynecol Oncol 2013;129: 277-84.
32. Kandoth C, Schultz N, Cherniack AD, Akbani R, Liu Y, Shen H, et al. Integrated genomic characterization of endometrial carcinoma. Nature 2013;497:67-73.
33. Rodriguez AM, Schmeler KM, Kuo YF. Disparities in endometrial cancer outcomes between non-Hispanic White and Hispanic women. Gynecol Oncol 2014;135:525-33.
34. Katzmarzyk PT, Staiano AE. New race and ethnicity standards: elucidating health disparities in diabetes. BMC Med 2012;10:42.
35. Ko EM, Walter P, Clark L, Jackson A, Franasiak J, Bolac C, et al. The complex triad of obesity, diabetes and race in Type I and II endometrial cancers: prevalence and prognostic significance. Gynecol Oncol 2014; 133:28-32.
36. Olson SH, Atoria CL, Cote ML, Cook LS, Rastogi R, Soslow RA, et al. The impact of race and comorbidity on survival in endometrial cancer. Cancer Epidemiol Biomarkers Prev 2012;21:753-60.
37. Reeves KW, Carter GC, Rodabough RJ, Lane D, McNeeley SG, Stefanick ML, et al. Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative. Gynecol Oncol 2011; 121:376-82.
38. Saltzman BS, Doherty JA, Hill DA, Beresford SA, Voigt LF, Chen C, et al. Diabetes and endometrial cancer: an evaluation of the modifying effects of other known risk factors. Am J Epidemiol 2008;167:607-14.
39. Zanders MM, BollD, van Steenbergen LN, van de Poll-Franse LV, Haak HR. Effect of diabetes on endometrial cancer recurrence and survival. Maturitas 2013;74:37-43.
40. Nevadunsky NS, Van Arsdale A, Strickler HD, Moadel A, Kaur G, Levitt J, et al. Obesity and age at diagnosis of endometrial cancer. Obstet Gynecol 2014;124:300-6.
41. Gilks CB, Oliva E, Soslow RA. Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma. Am J Surg Pathol 2013;37:874-81.
42. Morales LS, Lara M, Kington RS, Valdez RO, Escarce JJ. Socioeconomic, cultural, and behavioral factors affecting Hispanic health outcomes. J Health Care Poor Underserved 2002;13:477-503.
43. Cook LS, Nelson HE, Cockburn M, Olson SH, Muller CY, Wiggins CL. Comorbidities and endometrial cancer survival in Hispanics and non-Hispanic whites. Cancer Causes Control 2013;24:61-9.